Strikingly, we observed that in hereditary and secondary hemochromatosis the amount of retained iron of a 59Fe radiolabeled oral test dose of only 1 mg Fe(II) that was utilized for RBC production was lower when compared to the utilization of injected 59Fe radiolabeled transferrin-bound iron. Here, TF is linked to hemochromatosis type 1.